ScoreWhy is AB Science SA ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -8.32% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -12.24
2
Flat results in Jun 25
- CASH AND EQV(HY) Lowest at EUR 5.03 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -16.23%, its profits have fallen by -107.8%
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -16.23% returns in the last 1 year, the stock has also underperformed France CAC 40 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is AB Science SA for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
AB Science SA
-100.0%
-1.30
56.84%
France CAC 40
0.34%
-0.10
17.53%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-8.32%
EBIT Growth (5y)
9.25%
EBIT to Interest (avg)
-12.24
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
-0.26
Tax Ratio
22.87%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-3.02
EV to EBIT
-12.60
EV to EBITDA
-13.96
EV to Capital Employed
-6.81
EV to Sales
93.21
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
OPERATING CASH FLOW(Y)
Highest at EUR -11.33 MM
NET PROFIT(HY)
Higher at EUR -5.18 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 0.18 times
RAW MATERIAL COST(Y)
Fallen by -89.92% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -51.29 %
-1What is not working for the Company
CASH AND EQV(HY)
Lowest at EUR 5.03 MM
Here's what is working for AB Science SA
Net Profit
Higher at EUR -5.18 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (EUR MM)
Debtors Turnover Ratio
Highest at 0.18 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Operating Cash Flow
Highest at EUR -11.33 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (EUR MM)
Debt-Equity Ratio
Lowest at -51.29 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -89.92% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for AB Science SA
Cash and Eqv
Lowest at EUR 5.03 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
